Iambic Therapeutics Names William Rastetter Board Chairperson
- Iambic Therapeutics named William Rastetter board chair; he previously served as IDEC Pharmaceuticals CEO and Biogen Idec executive chairman.
- Samit Hirawat joined the board in August 2026.
- Hirawat served as Bristol Myers Squibb’s chief medical officer and head of global drug development from 2019 to 2025.
- Sunny Chang was promoted to general counsel.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iambic Therapeutics Inc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611160800PRIMZONEFULLFEED9877949) on November 16, 2026, and is solely responsible for the information contained therein.